FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082740344> ?p ?o ?g. }

• W3082740344 endingPage "1755" @default.
• W3082740344 startingPage "1748" @default.
• W3082740344 abstract "Male triple negative breast cancer (TNBC), which lacks expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is a very rare entity, comprising only a very small percentage of all male breast cancer cases. Management strategies are typically based off research conducted in female TNBC patients; however, there is still much that remains unknown in the male cohort, such as risk factors for developing these malignancies, the optimal treatment approach, and both short-term and long-term outcome data. In this retrospective cohort study, we aimed to address these concerns by assessing both the characteristics of male patients who develop TNBC as well as their outcomes. We harnessed data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program and identified 66 male patients diagnosed with TNBC between 2010 and 2016. Patients were stratified by several variables including age, insurance status, time period of diagnosis, histology, nodal status, tumor grade, tumor stage at diagnosis, and treatment strategy employed for the assessment of overall survival (OS) differences. Our analysis demonstrated that stage remains the most important prognostic factor for OS, with higher stage corresponding to worse OS. A significant OS benefit was also identified in men undergoing a total mastectomy, compared to partial mastectomy or no surgery at all. We also identified that male patients are more likely to present with more advanced disease stages compared to their female counterparts and, therefore, have worse outcomes on average. This may be due to various factors, including the rarity of male TNBC cases and less clear screening guidelines for male breast cancer in general. Trends toward poorer OS with higher tumor grade, higher tumor T stage, advanced age, earlier time period of diagnosis, and ductal histology were also identified, but did not achieve statistical significance. The remaining variables did not appear to influence outcomes in a meaningful manner. In summary, our study suggests, similar to population studies of women with TNBC, that tumor stage is a major prognostic factor of OS in men with TNBC. The data also suggest that the surgical treatment strategy employed is also likely of significance, with improved OS being seen with total mastectomies over partial mastectomies. Other variables such as tumor grade and T stage also likely play a role, but did not achieve statistical significance owing to the small population size. Owing to the rarity of cases, further studies of male TNBC are needed to better understand this rare entity and guide future management strategies." @default.
• W3082740344 created "2020-09-08" @default.
• W3082740344 creator A5037696116 @default.
• W3082740344 creator A5043433751 @default.
• W3082740344 creator A5052737403 @default.
• W3082740344 creator A5059723987 @default.
• W3082740344 creator A5079170582 @default.
• W3082740344 date "2020-08-27" @default.
• W3082740344 modified "2023-09-27" @default.
• W3082740344 title "Characteristics of male triple negative breast cancer: A population‐based study" @default.
• W3082740344 cites W1955397179 @default.
• W3082740344 cites W1978037194 @default.
• W3082740344 cites W1991046563 @default.
• W3082740344 cites W2015650529 @default.
• W3082740344 cites W2059655445 @default.
• W3082740344 cites W2062401605 @default.
• W3082740344 cites W2066500115 @default.
• W3082740344 cites W2067253523 @default.
• W3082740344 cites W2115802526 @default.
• W3082740344 cites W2141926802 @default.
• W3082740344 cites W2161426850 @default.
• W3082740344 cites W2170602872 @default.
• W3082740344 cites W2421692008 @default.
• W3082740344 cites W2592908133 @default.
• W3082740344 cites W2603868227 @default.
• W3082740344 cites W2766828098 @default.
• W3082740344 cites W2808444757 @default.
• W3082740344 doi "https://doi.org/10.1111/tbj.14023" @default.
• W3082740344 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32856383" @default.
• W3082740344 hasPublicationYear "2020" @default.
• W3082740344 type Work @default.
• W3082740344 sameAs 3082740344 @default.
• W3082740344 citedByCount "4" @default.
• W3082740344 countsByYear W30827403442021 @default.
• W3082740344 countsByYear W30827403442022 @default.
• W3082740344 countsByYear W30827403442023 @default.
• W3082740344 crossrefType "journal-article" @default.
• W3082740344 hasAuthorship W3082740344A5037696116 @default.
• W3082740344 hasAuthorship W3082740344A5043433751 @default.
• W3082740344 hasAuthorship W3082740344A5052737403 @default.
• W3082740344 hasAuthorship W3082740344A5059723987 @default.
• W3082740344 hasAuthorship W3082740344A5079170582 @default.
• W3082740344 hasBestOaLocation W30827403441 @default.
• W3082740344 hasConcept C107130276 @default.
• W3082740344 hasConcept C121608353 @default.
• W3082740344 hasConcept C126322002 @default.
• W3082740344 hasConcept C143998085 @default.
• W3082740344 hasConcept C146357865 @default.
• W3082740344 hasConcept C151730666 @default.
• W3082740344 hasConcept C167135981 @default.
• W3082740344 hasConcept C2777396416 @default.
• W3082740344 hasConcept C2777757722 @default.
• W3082740344 hasConcept C2778527826 @default.
• W3082740344 hasConcept C2779391198 @default.
• W3082740344 hasConcept C2780110267 @default.
• W3082740344 hasConcept C2908647359 @default.
• W3082740344 hasConcept C29456083 @default.
• W3082740344 hasConcept C530470458 @default.
• W3082740344 hasConcept C71924100 @default.
• W3082740344 hasConcept C72563966 @default.
• W3082740344 hasConcept C84606932 @default.
• W3082740344 hasConcept C86803240 @default.
• W3082740344 hasConcept C98717036 @default.
• W3082740344 hasConcept C99454951 @default.
• W3082740344 hasConceptScore W3082740344C107130276 @default.
• W3082740344 hasConceptScore W3082740344C121608353 @default.
• W3082740344 hasConceptScore W3082740344C126322002 @default.
• W3082740344 hasConceptScore W3082740344C143998085 @default.
• W3082740344 hasConceptScore W3082740344C146357865 @default.
• W3082740344 hasConceptScore W3082740344C151730666 @default.
• W3082740344 hasConceptScore W3082740344C167135981 @default.
• W3082740344 hasConceptScore W3082740344C2777396416 @default.
• W3082740344 hasConceptScore W3082740344C2777757722 @default.
• W3082740344 hasConceptScore W3082740344C2778527826 @default.
• W3082740344 hasConceptScore W3082740344C2779391198 @default.
• W3082740344 hasConceptScore W3082740344C2780110267 @default.
• W3082740344 hasConceptScore W3082740344C2908647359 @default.
• W3082740344 hasConceptScore W3082740344C29456083 @default.
• W3082740344 hasConceptScore W3082740344C530470458 @default.
• W3082740344 hasConceptScore W3082740344C71924100 @default.
• W3082740344 hasConceptScore W3082740344C72563966 @default.
• W3082740344 hasConceptScore W3082740344C84606932 @default.
• W3082740344 hasConceptScore W3082740344C86803240 @default.
• W3082740344 hasConceptScore W3082740344C98717036 @default.
• W3082740344 hasConceptScore W3082740344C99454951 @default.
• W3082740344 hasIssue "9" @default.
• W3082740344 hasLocation W30827403441 @default.
• W3082740344 hasOpenAccess W3082740344 @default.
• W3082740344 hasPrimaryLocation W30827403441 @default.
• W3082740344 hasRelatedWork W1991809109 @default.
• W3082740344 hasRelatedWork W2050936961 @default.
• W3082740344 hasRelatedWork W2370952237 @default.
• W3082740344 hasRelatedWork W2375815296 @default.
• W3082740344 hasRelatedWork W2497974553 @default.
• W3082740344 hasRelatedWork W2584184160 @default.
• W3082740344 hasRelatedWork W2953241133 @default.
• W3082740344 hasRelatedWork W2990538384 @default.
• W3082740344 hasRelatedWork W3082740344 @default.

• next